(Written by Michelle Tan)
With the continuous advancement of technology and increasing attention to health, the biopharmaceutical industry has become the focal point of the healthcare industry. The development and application of innovative drugs based on biotechnology, provide people with more treatment options and hopes for recovery. At the same time, the manufacturing technology in the biopharmaceutical industry is constantly upgrading, ensuring the production efficiency and guaranteeing the production of high-quality drugs on a large scale. In this rapidly developing field, one experienced practitioner has caught people’s attention, and that is XU Xincheng. With his deep understanding and significant contributions to the biopharmaceutical industry, XU Xincheng has won wide acclaim in the industry.
Since 2009, XU Xincheng has been dedicated to the biopharmaceutical industry. He has held positions related to pharmaceutical quality management in renowned pharmaceutical companies such as GE-Healthcare, WuXi Biologics Co.,Ltd., and Shanghai Bracco Sine Pharmaceutical Co., Ltd. Currently, he serves as the Vice President of Global Quality at Beijing Inno Medicine Co. Ltd., where he is responsible for the comprehensive quality management of the company’s products throughout the entire lifecycle. As the “top leader” in pharmaceutical quality management, XU Xincheng has strict control over every detail of the products, from drug quality management in the research and development phase to quality control in the clinical stage, and even tracking the quality of drugs after they are officially launched. He consistently holds his position and has successfully integrated the concept of quality management into research and development, ensuring the reliability, authenticity, and effectiveness of research and development data. He has also ensured the precision of clinical data down to every detail, guaranteeing the reasonability, accuracy, and safety of the trial subjects. During the production stage, XU Xincheng actively introduced advanced quality management systems, making the production process more standardized and controllable. His innovation and progress have ensured that patients both domestically and internationally can access the same high-quality and effective drugs. His emphasis on equipment management and management of third-party suppliers has ensured proper control of every procedure in the production process.
In addition to his professional work in quality management, XU Xincheng has also demonstrated strong innovative capabilities in the field of biopharmaceuticals. He closely follows the forefront of industry development, fearlessly innovates, and combines the latest technological means, such as big data and artificial intelligence, to independently develop a series of industry-leading technological achievements. These achievements include the “Data-driven Biopharmaceutical Quality Management System,” “Big Data-based Biopharmaceutical Supply Chain Optimization System,” and “Comprehensive Supervision System for Drug Testing.” These innovative achievements have greatly improved the work efficiency of pharmaceutical companies and filled the gaps in flexibility and data processing speed in the existing systems of quality management. XU Xincheng’s innovative achievements stem from his deep understanding and visionary perspective of the biopharmaceutical industry, as well as his willingness to explore and apply new technologies. XU Xincheng’s innovation represents a profound transformation of the traditional development model in the biopharmaceutical industry.
With his outstanding innovation capabilities and extensive industry influence, XU Xincheng has been awarded the “2022 Outstanding Digital Innovation Figure Award” and the “2023 Biopharmaceutical Industry Influential Figure Award” for two consecutive years. His achievements and contributions demonstrate how to effectively integrate professional knowledge and new technologies to deliver value to the industry. People see in him an exceptional practitioner who drives industry progress and uses an innovative perspective to interpret and meet industry needs.
For newcomers entering the biopharmaceutical industry, XU Xincheng has his own advice and expectations. XU Xincheng said, “We need to have a strong sense of responsibility and mission. We must fully grasp the trends in new biopharmaceutical technologies and the development of the biopharmaceutical industry. We should timely update our knowledge structure and strive to participate in or initiate new scientific research projects. The biopharmaceutical industry is highly specialized, and we need to put our heart into every job to ensure the quality and safety of pharmaceutical products.” His advice is not only for newcomers but also for the future of the entire industry. He hopes that newcomers in the biopharmaceutical industry can, like him, contribute to the development of the industry with professional knowledge and great enthusiasm.
XU Xincheng combines expertise, innovative thinking, and leadership, making significant contributions to the prosperity and development of the entire industry. His career and personal achievements exemplify his role as a true leader in the biopharmaceutical industry. Without a doubt, XU Xincheng is an important participant and leader in the biopharmaceutical industry.
